Allergan's anti-PTAB patent deal with the Mohawks looks to be a potential US game-changer

Allergan may just have driven a coach and horses through the inter partes review process at the Patent Trial and Appeal Board. The company’s agreement to transfer the six patents underpinning its dry-eye treatment Restasis to the Saint Regis Mohawks…

Unlock unlimited access to all IAM content